Fischer Angling For Swift Mammography Device Review Following IoM Report
This article was originally published in The Gray Sheet
Executive Summary
Fischer Imaging's hopes for a relatively quick turnaround of its March 12 PMA submission for the SenoScan digital mammography system could be boosted by the possibility that the device will not have to go before an FDA advisory panel, the Denver-based firm said.